Acute Stroke — Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
Citation(s)
Demanboro A, Sterr A, Anjos SMD, Conforto AB A Brazilian-Portuguese version of the Kinesthetic and Visual Motor Imagery Questionnaire. Arq Neuropsiquiatr. 2018 Jan;76(1):26-31. doi: 10.1590/0004-282X20170181.
Liepert J, Büsching I, Sehle A, Schoenfeld MA Mental chronometry and mental rotation abilities in stroke patients with different degrees of sensory deficit. Restor Neurol Neurosci. 2016 Nov 22;34(6):907-914.
Liepert J, Greiner J, Nedelko V, Dettmers C Reduced upper limb sensation impairs mental chronometry for motor imagery after stroke: clinical and electrophysiological findings. Neurorehabil Neural Repair. 2012 Jun;26(5):470-8. doi: 10.1177/1545968311425924. Epub 2012 Jan 13.
Malouin F, Richards CL, Jackson PL, Lafleur MF, Durand A, Doyon J The Kinesthetic and Visual Imagery Questionnaire (KVIQ) for assessing motor imagery in persons with physical disabilities: a reliability and construct validity study. J Neurol Phys Ther. 2007 Mar;31(1):20-9.
Randhawa B, Harris S, Boyd LA The Kinesthetic and Visual Imagery Questionnaire is a reliable tool for individuals with Parkinson disease. J Neurol Phys Ther. 2010 Sep;34(3):161-7.
Tabrizi YM, Zangiabadi N, Mazhari S, Zolala F The reliability and validity study of the Kinesthetic and Visual Imagery Questionnaire in individuals with multiple sclerosis. Braz J Phys Ther. 2013 Nov-Dec;17(6):588-92. doi: 10.1590/S1413-35552012005000124. Epub 2013 Nov 14.
Investigation of Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
